s20098 has been researched along with Adverse Drug Event in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fischer, G; Fong, G; Kherlopian, A | 1 |
| Akaras, N; Atilay, H; Bal, T; Halici, MB; Selli, J | 1 |
3 other study(ies) available for s20098 and Adverse Drug Event
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug reaction with eosinophilia and systemic symptoms due to agomelatine.
Topics: Acetamides; Anxiety; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Female; Humans; Hypnotics and Sedatives; Middle Aged | 2021 |
Protective effects of agomelatine on testicular damage caused by bortezomib.
Topics: Acetamides; Animals; Antineoplastic Agents; Bortezomib; Drug-Related Side Effects and Adverse Reactions; Immunohistochemistry; Male; Oxidative Stress; Rats, Sprague-Dawley; Reference Standards; Superoxide Dismutase; Testis | 2017 |